Literature DB >> 19041887

Epidemiology of chronic kidney disease: results from a population of older adults in Germany.

Qiu-Li Zhang1, Wolfgang Koenig, Elke Raum, Christa Stegmaier, Hermann Brenner, Dietrich Rothenbacher.   

Abstract

OBJECTIVE: To determine prevalences and stages of chronic kidney disease (CKD), and evaluate association of CKD with related covariables in a large population of older adults.
METHODS: This cross-sectional analysis included 9806 participants of a general health check-up aged 50-74 years in Germany. We performed multivariate analysis to identify association of CKD with related covariables. Partial spearman correlations of eGFR with related biomarkers were calculated.
RESULTS: Overall, 17.4% of subjects had CKD. Prevalences of stages 1, 2, 3, 4/5 CKD were 4.6%, 4.7%, 17.0% and 0.4%, respectively. Prevalence of CKD increased with age and peaked in age 70-74 years with 23.9%. In multivariable analysis of older age, female, self-reported history of cardiovascular diseases, diabetes and statin usage were independently associated with increased risk for CKD. Significant correlations were found between eGFR and serum cystatin C (-0.28), C-reactive protein (-0.04), fasting glucose (0.12), HbA(1c) (-0.06), total cholesterol (-0.32), and triglycerides (-0.07) after adjustment for covariates.
CONCLUSIONS: This study shows a high prevalence of CKD among older adults. It highlights the association of eGFR with history of cardiovascular diseases, glycemic markers, and cardiovascular risk factors and may point to further possible targets in early prevention of CKD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041887     DOI: 10.1016/j.ypmed.2008.10.026

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  27 in total

1.  The Oldest Old in the Emergency Department: Impact of Renal Function.

Authors:  T Brünnler; M Drey; G Dirrigl; C Weingart; F Rockmann; C Sieber; U Hoffmann
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

2.  Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland.

Authors:  Aghogho Okparavero; Meredith C Foster; Hocine Tighiouart; Vilmundur Gudnason; Olafur Indridason; Hrefna Gudmundsdottir; Gudny Eiriksdottir; Elias F Gudmundsson; Lesley A Inker; Andrew S Levey
Journal:  Nephrol Dial Transplant       Date:  2015-10-31       Impact factor: 5.992

3.  Cystatin C versus creatinine in determining risk based on kidney function.

Authors:  Michael G Shlipak; Kunihiro Matsushita; Johan Ärnlöv; Lesley A Inker; Ronit Katz; Kevan R Polkinghorne; Dietrich Rothenbacher; Mark J Sarnak; Brad C Astor; Josef Coresh; Andrew S Levey; Ron T Gansevoort
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

4.  Arterial stiffness and impaired renal function in patients with Alzheimer's disease.

Authors:  Yoon-Sang Oh; Joong-Seok Kim; Jeong-Wook Park; Jae-Young An; Sung Kyung Park; Yong-Soo Shim; Dong-Won Yang; Kwang-Soo Lee
Journal:  Neurol Sci       Date:  2015-12-18       Impact factor: 3.307

5.  Disorders of lipid metabolism and chronic kidney disease in the elderly.

Authors:  Devasmita Choudhury; Meryem Tuncel; Moshe Levi
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

6.  Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector.

Authors:  Willem P Meuwesen; Jesslee M du Plessis; Johanita R Burger; Martie S Lubbe; Marike Cockeran
Journal:  Int J Clin Pharm       Date:  2016-04-18

7.  Kidney function is associated with the rate of cognitive decline in the elderly.

Authors:  Aron S Buchman; D Tanne; P A Boyle; R C Shah; S E Leurgans; D A Bennett
Journal:  Neurology       Date:  2009-08-05       Impact factor: 9.910

8.  Age and association of kidney measures with mortality and end-stage renal disease.

Authors:  Stein I Hallan; Kunihiro Matsushita; Yingying Sang; Bakhtawar K Mahmoodi; Corri Black; Areef Ishani; Nanne Kleefstra; David Naimark; Paul Roderick; Marcello Tonelli; Jack F M Wetzels; Brad C Astor; Ron T Gansevoort; Adeera Levin; Chi-Pang Wen; Josef Coresh
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

Review 9.  Intravenous immunoglobulin and Alzheimer's disease: what now?

Authors:  David A Loeffler
Journal:  J Neuroinflammation       Date:  2013-06-05       Impact factor: 8.322

10.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

Authors:  Kunihiro Matsushita; Bakhtawar K Mahmoodi; Mark Woodward; Jonathan R Emberson; Tazeen H Jafar; Sun Ha Jee; Kevan R Polkinghorne; Anoop Shankar; David H Smith; Marcello Tonelli; David G Warnock; Chi-Pang Wen; Josef Coresh; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey
Journal:  JAMA       Date:  2012-05-09       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.